Croma-Pharma GmbH
Quick facts
Marketed products
- Botulinum toxin A "Botox Cosmetics" · Dermatology; Aesthetics; Neurology
Botulinum toxin A blocks the release of acetylcholine at the neuromuscular junction, causing temporary paralysis of muscles.
Phase 3 pipeline
- Botulinum Toxin A - Open Label · Neurology; Aesthetics; Pain Management
Botulinum Toxin A blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: